ArticleCancer science2010

Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells.

Carla Cavaliere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.